Previous close | 218.22 |
Open | 218.58 |
Bid | 215.18 x 1400 |
Ask | 222.88 x 1100 |
Day's range | 218.58 - 222.17 |
52-week range | 187.16 - 351.86 |
Volume | |
Avg. volume | 1,014,559 |
Market cap | 32.069B |
Beta (5Y monthly) | 0.40 |
PE ratio (TTM) | 16.00 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Ionis (IONS) incurs a wider-than-expected loss in Q2. Its sales also miss estimates. Stock moves down in response to the results.
Denali (DNLI) incurs narrower-than-expected Q2 loss while collaboration revenues beat estimates.
Raymond James Healthcare Policy Analyst Chris Meekins joins Yahoo Finance Live to discuss the expectations for the Manchin-Schumer deal, expanding regulation on drug prices, out-of-pocket Medicare expenses, and the outlook for pharmaceutical company earnings.